JC-63.1

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameJC-63.1

Drug Alias NameJC-63-1JC-63.1

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPlatelet glycoprotein 4 modulators

TargetsPlatelet glycoprotein 4

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMcGill University

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesMcGill University

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A